Summary: District Of Columbia Trinity College; Letter of Credit Sep 11

  • ID: 1927669
  • September 2011
  • Standard & Poors
1 of 3


  • District of Columbia
  • Trinity Coll
  • MORE

Standard & Poor's Ratings Services affirmed its 'AA/A-1+' rating on District of Columbia's (Trinity College) variable-rate revenue bonds series 2001, due to the bank facility being extended to July 13, 2012. The long-term and short-term components of the rating are based on the rating on Wells Fargo Bank N.A., South Dakota. Criteria: Methodology And Assumptions: Approach To Evaluating Letter Of Credit-Supported Debt, July 6, 2009...

Companies mentioned in this report are:
- Trinity Coll
- District of Columbia

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3

- Trinity Coll
- District of Columbia

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.